HOME>HOME>For Our Shareholders and Investors>ASKA Pharmaceutical Holdings at a glance

ASKA Pharmaceutical Holdings at a glance

View ASKA Pharmaceutical Holdings in Report and Video

Corporate Profile

Integrated Report "ASKA HD REPORT" (2024)

Related Contents

Benefits of Becoming a Shareholder of ASKA Pharmaceutical Holdings

Contribute to Women's Healthcare and Animal Welfare

Through our business activities, we contribute to "total support for women's health" and "creating a society where people and animals can coexist in harmony. In the field of women's health care in particular, as more women participate in society, concerns about women's health and illnesses are becoming more diverse and apparent. To respond to a wide range of such concerns, we strive to provide women with opportunities to make choices for healthy living, not only through pharmaceuticals but also through disseminating of information necessary for staying healthy and confronting illness.
By becoming a shareholder of ASKA Pharmaceutical Holdings, you can contribute to society through your thoughts and ideas. Together with our shareholders, we aim to realize a prosperous society.

Participate in the business management of the Company

You can participate in the Annual General Meeting of Shareholders held each year. You can also participate in management by voting on important resolutions according to the number of shares you own.

Receive stable dividends

We consider the return of profits to our shareholders as one of the most important management issues. For more than 40 years, we have not reduced dividends, even under severe business conditions. We will continue to distribute profits based on stable dividends, considering consolidated operating results, medium- to long-term capital needs, and our financial position.

Inquiries about shareholder and investor information

For any inquiries to our company, please fill out the inquiry form.

*Please note that we may not be able to reply to your inquiry depending on the content of your inquiry.